{"disease":{"id":"schizophreniform-schizophrenic","name":"schizophreniform schizophrenic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05025605","title":"Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"BioXcel Therapeutics Inc","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}